Period Ending | Dec 30, 2012 | Dec 30, 2011 |
---|
Total Revenue
|
179,460,000
|
196,088,000
| Cost of Revenue | 158,515,000 | 176,909,000 | |
Gross Profit
|
20,945,000
|
19,179,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 15,463,000 | 15,697,000 |
|
Non Recurring | 1,158,000 | 472,000 |
|
Others | 938,000 | 929,000 |
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
3,386,000
|
2,081,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 357,000 | 1,717,000 |
|
Earnings Before Interest And Taxes | 6,877,000 | 6,641,000 |
|
Interest Expense | 246,000 | 17,000 |
|
Income Before Tax | 6,631,000 | 6,624,000 |
|
Income Tax Expense | 2,500,000 | 1,844,000 |
|
Minority Interest | (7,000) | (5,000) |
|
|
|
Net Income From Continuing Ops | 7,258,000 | 7,618,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
4,124,000
|
4,775,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
4,124,000
|
4,775,000
|
|